Fusion Antibodies (FAB)

Sector:

Health Care

Index:

FTSE AIM All-Share

6.30p
   
  • Change Today:
    -0.050p
  • 52 Week High: 10.20p
  • 52 Week Low: 2.90p
  • Currency: UK Pounds
  • Shares Issued: 113.66m
  • Volume: 579,817
  • Market Cap: £7.16m
  • RiskGrade: 464
  • Beta: 0.01

FAB Overview

Fusion Antibodies is a Collaborative Research Organisation (CRO) with its headquarters in Northern Ireland. We are world leaders in antibody development services specializing in the discovery, engineering and supply of pre-clinical biologics through to clinical Cell Line Development.

1 Day Chart (11-07-2025)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -201.4% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 6.3 n/a
Pr/Book 4.0  
Latest F'cast
Revenue -60.8% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

FAB Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-20 3.90 (1.07) (3.20)p n/a n/a n/a n/a 0.0%
31-Mar-21 4.16 (1.26) (0.12)p n/a n/a n/a n/a 0.0%
31-Mar-22 4.80 (1.33) (4.60)p n/a n/a n/a n/a 0.0%
31-Mar-23 2.90 (2.86) (10.00)p n/a n/a n/a n/a 0.0%
31-Mar-24 1.14 (2.29) (3.90)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

FAB Company Announcements

Director/PDMR Shareholding 11-Jul-2025 07:00 RNS
Total Voting Rights 02-Jun-2025 07:00 RNS
Update on U.S. Patent for OptiMAL® 22-May-2025 14:33 RNS

FAB ShareCast News

Fusion Antibodies validation project with US NIC... 31-Jan-2025 ShareCast
Fusion Antibodies reports positive recent trading 08-Oct-2024 ShareCast
Fusion Antibodies strengthens financial position... 05-Sep-2024 ShareCast

Latest FAB Director Deals

Traded Action Notifier PriceAmountValue
07-Jul-25 Transfer From Colin Walsh 0.000p 269,889 £0.00
06-May-25 Buy Matthew Baker 6.10p 55,327 £3,374.95
06-May-25 Buy Colin Walsh 6.10p 221,331 £13,501.19

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

FAB Market Data

Currency UK Pounds
Share Price 6.30p
Change Today -0.050p
% Change -0.79 %
52 Week High 10.20p
52 Week Low 2.90p
Volume 579,817
Shares Issued 113.66m
Market Cap £7.16m
Beta 0.01
RiskGrade 464

FAB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
43.9% below the market average43.9% below the market average43.9% below the market average43.9% below the market average43.9% below the market average
9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average
Price Trend
18.93% below the market average18.93% below the market average18.93% below the market average18.93% below the market average18.93% below the market average
14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average14.29% above the sector average
Income Not Available
Growth
25.73% below the market average25.73% below the market average25.73% below the market average25.73% below the market average25.73% below the market average
25.71% below the sector average25.71% below the sector average25.71% below the sector average25.71% below the sector average25.71% below the sector average

FAB Dividends

No dividends found

Trades for 11-Jul-2025

Time Volume / Share Price
16:29 7 @ 6.40p
16:29 8 @ 6.40p
15:28 175,000 @ 6.26p
16:23 8 @ 6.40p
16:16 7 @ 6.40p

FAB Key Personnel

Chair Simon Gordon Douglas
CEO Adrian Kinkaid

Top of Page